Due to our results showing the association between liprin-α1 and CD82, we explored the significance of PPFIA1 amplification in survival of clinical HNSCC and breast cancer patients from The Cancer Genome Atlas (TCGA) data. This evidence concerns the gene CD82 and breast carcinoma.